ProteinLogic Ltd logo — company profile

ProteinLogic Ltd

Founded 2003 United Kingdom Cambridge, United Kingdom 1 employees Grant Total: $4.93M Health Care, Medical Devices

General Information

Company Name ProteinLogic Ltd
Founded Year 2003
Location United Kingdom Cambridge, United Kingdom +1
Employees 1
Industries Health Care, Medical Devices
Funding Stage Grant
Social

Get notified when ProteinLogic Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ProteinLogic Ltd

ProteinLogic, founded in 2003, is a Health Care startup based in the United Kingdom. The company has developed ImmiPrint® - a cutting-edge technology platform designed for the diagnosis of tuberculosis (TB), a global health challenge. The last investment round saw a significant injection of $1.35M in grant funding on 24 January 2024, with the Bill & Melinda Gates Foundation stepping in as investors. ProteinLogic's focus on TB diagnosis is particularly poignant, given the disease's status as one of the most significant infectious diseases worldwide, alongside HIV/AIDS. Their ImmiPrint® platform holds the potential to revolutionize TB diagnostics by offering an effective blood-based diagnostic tool, as well as providing valuable insights into disease progression. Additionally, the platform may have the capability to predict which individuals are likely to respond positively to anti-microbial therapy. Overall, ProteinLogic's groundbreaking approach to tackling TB and their recent injection of funding from a prominent global player indicate a promising trajectory for the company as it continues to address a critical global health issue.

Taxonomy: diagnostic technology, tuberculosis, ImmiPrint® platform, infectious disease, blood-based test, disease progression, anti-microbial therapy

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
24 Jan 2024
Grant •••••• 1 •••• •••• 01 Jul 2015

ProteinLogic Ltd Alternatives & Competitors

ProteinLogic Ltd vs
Orbit Genomics
Orbit Genomics United States

The Future of Precision Healthcare

Unknown
8 employees
ProteinLogic Ltd vs

Empowering care with validated AI-driven tools for early detection and better management of neurolog...

Non Equity Assistance
22 employees
Life Sciences, Medical Devices
ProteinLogic Ltd vs

Decoding disease using multiomics

Seed
19 employees
Biotechnology, Life Sciences

FAQ About ProteinLogic Ltd

ProteinLogic has developed a novel technology platform (ImmiPrint®) focused on the diagnosis of tuberculosis (TB). Along with HIV/AIDS, TB is the most significant infectious disease worldwide. Early and accurate diagnosis is essential for its control. The ImmiPrint® platform has the potential to de...
ProteinLogic Ltd was founded in 2003.
ProteinLogic Ltd is headquartered in Cambridge, United Kingdom.
ProteinLogic Ltd operates in the following industries: Health Care, Medical Devices.
ProteinLogic Ltd has approximately 1 employees.
ProteinLogic Ltd has completed 2 funding rounds, raising a total of $4.93M. The latest funding stage is Grant.
Top alternatives and competitors to ProteinLogic Ltd include Orbit Genomics, Head Diagnostics, Tagomics, Fideliomed, Hunterdon Gastroenterology Associates. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ProteinLogic Ltd and Orbit Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ProteinLogic Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy